Cantor raises NewAmsterdam Pharma stock price target to $61
AI Summary
Cantor raised its price target for NewAmsterdam Pharma to $61. The brief report does not state the previous target or explain the rationale for the increase.
Related Articles
American Integrity Insurance Group, Inc. (AII) Q3 2026 Earnings Call Transcript
Seeking Alpha —
Riskified Ltd. (RSKD) Q3 2026 Earnings Call Transcript
Seeking Alpha —
ITG, Inc. (ITG) Q3 2026 Earnings Call Transcript
Seeking Alpha —
U.S. Efforts to Tighten Blockade of Iran Rely on Reluctant Neighbors
New York Times World —
Leader aide warns of consequences for those supporting hostile economic blockade against Iran
Tehran Times —
FG clears pension backlog, funds benefits until 2029
Punch Nigeria —